T1	intervention 0 26	Bisphosphonate risedronate
T2	condition 36 45	bone loss
T3	eligibility 49 117	women with artificial menopause due to chemotherapy of breast cancer
T4	No-of-participants 413 424	Fifty-three
T5	ethinicity 425 430	white
T6	average-age 443 457	36 to 55 years
T8	intervention-participants 694 696	27
T9	control 701 708	placebo
T7	control-participants 714 716	26
T10	outcome-Measure 955 1114	changes in lumbar spine and proximal femur (femoral neck, trochanter, and Ward's triangle) bone mineral density (BMD), and biochemical markers of bone turnover
T11	outcome 1157 1188	BMD at the lumbar spine and hip
T12	outcome 1291 1300	bone loss
